WallStreetZenWallStreetZen

NASDAQ: ATOS
Atossa Therapeutics Inc Stock Ownership - Who owns Atossa Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Atossa Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Steven C. QuayPresident CEO2025-05-2111,239$0.88
$9.89kBuy
H. Lawrence RemmelDirector2025-03-2610,000$0.70
$7.00kBuy

1 of 1

ATOS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ATOS insiders and whales buy or sell their stock.

ATOS Shareholders

What type of owners hold Atossa Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Shuchih Chen7.04%9,095,173$5.14MInsider
Vanguard Group Inc4.71%6,078,844$3.43MInstitution
Steven C. Quay4.02%5,194,684$2.93MInsider
Ameriprise Financial Inc2.28%2,951,505$1.67MInstitution
Blackrock Inc1.55%1,997,627$1.13MInstitution
Millennium Management LLC1.29%1,668,648$942.79kInstitution
Renaissance Technologies LLC1.20%1,548,663$874.99kInstitution
Geode Capital Management LLC1.05%1,362,282$769.69kInstitution
State Street Corp0.35%454,495$256.79kInstitution
Gsa Capital Partners LLP0.24%310,754$175.58kInstitution

1 of 3

ATOS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ATOS15.00%11.29%Net Buying
PTHS7.61%92.39%Net BuyingNet Selling
COEP0.97%99.03%
PYPD18.10%0.00%
PLRX65.80%34.20%Net SellingNet Selling
View Top Biotech Stocks

Atossa Therapeutics Stock Ownership FAQ

Who owns Atossa Therapeutics?

Atossa Therapeutics (NASDAQ: ATOS) is owned by 15.00% institutional shareholders, 11.29% Atossa Therapeutics insiders, and 73.70% retail investors. Shuchih Chen is the largest individual Atossa Therapeutics shareholder, owning 9.10M shares representing 7.04% of the company. Shuchih Chen's Atossa Therapeutics shares are currently valued at $5.14M.

If you're new to stock investing, here's how to buy Atossa Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.